Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development 05-Oct-2021 By Rachel Arthur Dynavax will conduct a Phase 2 clinical trial combining the US Department of Defense’ rF1V vaccine with its CpG 1018 adjuvant.
Gates Foundation gives Dynavax COVID-19 grant to scale up adjuvant production 17-Aug-2020 By Nick Taylor Dynavax gets Bill & Melinda Gates Foundation funding to scale up production of adjuvant for use in COVID-19 vaccines.